Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Six patients with Obsessive-Compulsive Disorder (DSM III) were treated in an open uncontrolled trial with Zimeldine, for 8 weeks. All six patients had cognitive deficits before treatment. Five patients improved on the clinical symptoms. Four of these showed pronounced amelioration of their cognitive deficits.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on